Sangamo Therapeutics
SGMO
SGMO
205 hedge funds and large institutions have $691M invested in Sangamo Therapeutics in 2020 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 77 increasing their positions, 47 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
8% more funds holding
Funds holding: 190 → 205 (+15)
9.43% less ownership
Funds ownership: 64.16% → 54.73% (-9.4%)
Holders
205
Holding in Top 10
–
Calls
$15.5M
Puts
$10.5M
Top Buyers
| 1 | +$14.7M | |
| 2 | +$10.6M | |
| 3 | +$8.67M | |
| 4 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$8.48M |
| 5 |
GLA
Great Lakes Advisors
Chicago,
Illinois
|
+$7.55M |
Top Sellers
| 1 | -$14.7M | |
| 2 | -$10.2M | |
| 3 | -$9.48M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$8.68M |
| 5 |
TCM
Tang Capital Management
San Diego,
California
|
-$4.07M |